In what types of solid tumors has genomic alteration-directed therapy guided by NGS been shown to improve patient outcomes, including progression-free survival and overall (OS)? (Portuguese)

In what types of solid tumors has genomic alteration-directed therapy guided by NGS been shown to improve patient outcomes, including progression-free survival and overall (OS)? (Portuguese)

In what types of solid tumors has genomic alteration-directed therapy guided by NGS been shown to improve patient outcomes, including progression-free survival and overall (OS)? (Portuguese)


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Prof. Luis Costa, MD, PhD

Prof. Luis Costa, MD, PhD

Professor of Medicine, Medical Faculty
Lisbon University
Director of the Oncology Division
Hospital de Santa Maria
Lisbon, Spain